ABOUT ELLIGO HEALTH RESEARCH

Elligo Health Research, a healthcare-enabling research organization, uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option. Powered by our Goes Direct® approach and novel IntElligo® Research Stack clinical technology, our team provides access to the best healthcare experts, patients, and research technologies. We engage physicians and patients who otherwise would not participate in clinical research and accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products. Learn more at elligodirect.com.

WEBINARS AND VIDEOS

  • IntElligo® Research Stack technology is the only system designed to work in a real-world healthcare environment, collecting data at the point of care using CDISC global research data standards and automatically preparing it for regulatory compliance and submission.

  • Decentralized clinical trials (DCTs), which were encouraged by the FDA as a means to modernize clinical trials per the 21st Century Cures Act, have received new interest during the pandemic. Consideration for safety of study participants and clinicians in this changing world demands a new paradigm for research. In this webinar you will learn more about the characteristics of DCTs and hybrid trials, a spectrum of approaches to DCTs, SDR and how it aligns with risk-based monitoring and differs from source data verification (SDV), and opportunities to leverage eSource technology.

  • The COVID-19 pandemic has made the benefits of decentralized or hybrid trial models even more obvious, and as travel restrictions, social distancing and the overall strain on the healthcare system became more evident, the FDA updated regulations to fast-track research, openly recognizing the value of alternative technology such as virtual trial capabilities in clinical research. This webinar will explore how COVID-19 pushed the industry to adapt to tech-enabled solutions for patients and sponsors.

  • New treatment options can only become realities when clinical trials are fully enrolled. Learn how Elligo is improving access to clinical trials for patients by bringing research as care options to their physician’s office.